Shapiro, Robert E.
Hochstetler, Helen M. http://orcid.org/0000-0002-7428-4355
Dennehy, Ellen B.
Khanna, Rashna
Doty, Erin Gautier
Berg, Paul H.
Starling, Amaal J.
Article History
Received: 30 May 2019
Accepted: 20 August 2019
First Online: 29 August 2019
Ethics approval and consent to participate
: These studies were conducted in accordance with the principles of the Declaration of Helsinki. The institutional review board or independent ethics committee at each site approved the protocols, and all patients provided written informed consent. All authors had access to the study data and have reviewed and approved the final manuscript.
: Not applicable.
: RES was a Lilly-paid consultant for galcanezumab clinical trials Data Monitoring Committee. HMH, EBD, RK, EGD, and PHB are all employees and shareholders of Eli Lilly and Company and/or one of its subsidiaries. EGD was also an advisory board member for Eli Lilly prior to her employment and served on speakers’ bureaus for Allergan Botox, Amgen, and Teva. AJS served as a consultant for Alder, eNeura, Amgen, Eli Lilly and Company, and Novartis. AJS also received grant funding from the Migraine Research Foundation - Mayo Clinic Intramural funding.